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Joint reanalysis of 29 correlated SNPs supports the role of
PCLO/Piccolo as a causal risk factor for major depressive
disorder
Molecular Psychiatry (2009) 14, 650–652;
doi:10.1038/mp.2009.37
The first genome-wide association study (GWAS) for
major depressive disorder (MDD) has implicated the
pre-synaptic protein, Piccolo, but results from multi-
ple replication cohorts remained inconclusive. Here,
we present a reanalysis of the Piccolo replication
study and argue that the data favor a non-synonymous
coding single nucleotide polymorphism (SNP) in a
well-characterized protein domain to be a causal risk
factor for major depression.
In the first GWAS for MDD, multiple SNPs within
the PCLO gene that codes for the pre-synaptic protein,
Piccolo, reached nominal P-values in the magnitude
of 107.1 One of the most strongly associated SNPs
was rs2522833, a non-synonymous coding SNP in a
well-characterized protein domain, the C2-domain, of
Piccolo. A panel of 30 SNPs was followed up in a
finemapping/replication effort that involved five
additional MDD cohorts. In the replication stage, a
nominally significant P-value was observed for
rs2522833 in one cohort. Although these results are
highly suggestive, the original finding did not reach
genome-wide significance, and after permutation-
based correction for testing multiple correlated SNPs
and cohorts, the replication study was not conclu-
sive.1
Here, we present a reanalysis of the PCLO replica-
tion study and conclude that Sullivan et al. provide
convincing evidence to claim the association of
rs2522833, a potentially causal variant in a biologi-
cally plausible candidate gene, with MDD. Our
approach is based on two observations. First, fine-
mapping studies focus on a limited number of
correlated SNPs. All tested SNPs are expected to
reflect the true association of the unknown causal
variant proportional to their LD with it. This
phenomenon is better known as the ‘Fundamental
Theorem of the HapMap’,2 and although it has
received some criticism,2,3 it is generally accepted
that the observed effect at a neutral SNP is the
product of the causal effect and the correlation
between the causal and neutral loci (that is, LD).
Second, given such correlated SNP data, it has been
suggested before that a joint analysis of all markers
together is most powerful for detecting a true
association. A joint analysis de facto summarizes
the information from many neighboring SNPs to
provide one joint test of association (for review, see
Bacanu4), hence no correction for testing multiple
SNPs is needed.
A closer examination of the results reported by
Sullivan et al. shows that the data indeed concur with
the ‘Theorem of the HapMap’. Sullivan et al. report in
Table 4a the Z-scores of the association between each
individual SNP and MDD in the original cohort used
for the GWAS. From the HapMap data, the LD is
known between rs2522833 and 28 of the remaining 29
SNPs. Interestingly, the correspondence between the
absolute value of the Z-scores observed by Sullivan
et al. and the square root of r2 from HapMap is striking
(Figure 1). Most of the observed association between
the genotype data and MDD is explained (r = 0.92) by
the association of rs2522833 with MDD and the local
LD structure of PCLO. The data are consistent with
the hypothesis that either rs2522833 or a variant in
very high LD with rs2522833 is a causal risk factor for
MDD. It should be noted that an earlier study has
confirmed that the local LD structure in the PCLO
region is highly similar between the HapMap CEU
panel and the Dutch population sample used in this
study.5
On the basis of the above, we propose that the
replication data can be analyzed by a joint measure of
association and local LD, similar to a recently
reported method.6 The specific hypothesis to address
is the following: the non-synonymous coding SNP,
rs2522833, is causally related to MDD, and the
neighboring SNPs show associations proportional to
their LD with rs2522833. To make use of the summary
statistics reported in Table 4a by Sullivan et al., and
the representation of the ‘Theorem of the HapMap’
depicted in Figure 1, we estimated the joint prob-
ability distribution of the Z-score for rs2522833 (Z)
and the correlation coefficient between Z-scores
and LD relative to rs2522833 (C) under the null
hypothesis of no association of rs2522833 with
MDD. This joint distribution was determined
empirically from simulations using GWAsimulator.7
From this empirical distribution, the joint probability
was calculated for the observed values of Z = T2
and C = T1.
PðcorrelðabsfZ1::ng; absfr1::n;xgÞ4T1; Zx4T2Þ ð1Þ
This probability is not the P-value for the test, because
combinations other than the observed values, Z = T2
and C = T1, can also reach joint probabilities equally
low or lower. The correct P-value is given by the
proportion of all possible combinations of Z and C
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with a joint probability lower than that which is
observed for Z = T2 and C = T1.
Sullivan et al. report on five replication cohorts.
One of these five was a posteriori described to be
more similar to the original sample than the others
because both studies included population-based
cases, and controls were selected for low liability for
MDD. In this (Australian) cohort, a nominally sig-
nificant replication of the association between MDD
and rs2522833 was observed: Z = 2.19 (T2). Our
parameter T1 is 0.61 for this cohort. The joint
probability is 0.008 and the P-value to observe such
unlikely combinations of Z and C is 0.02 (Figure 2).
Although the other four cohorts did not show
evidence of association (data not shown), the present
reanalysis of data favors the alternative hypothesis
that rs2522833 (or an unknown SNP in strong LD with
it) is a causal risk factor for MDD.
In addition, simulations were carried out with
various realistic effect sizes for rs2522833 (Figure 2).
Compared with the null hypothesis of no replication,
the scenario that the non-synonymous SNP,
rs2522833, is a causal variant (or in strong LD with
it) is 30–50 times more probable, assuming realistic
relative risks of 1.2 through to 1.5. An alternative
interpretation of these results is that if the true effect
of rs2522833 in the Australian cohort were RR = 1.3,
the present joint analysis of 29 SNPs has an 87%
probability of correctly calling for a true association.
Hence, the replication study had sufficient statistical
power when performing the joint analysis as pro-
posed here, to confirm the association between PCLO
and MDD.
From this reanalysis, we conclude that Sullivan
et al. provide convincing evidence for the potentially
causal association of the non-synonymous coding
SNP rs2522833 in PCLO/Piccolo with MDD. When
combining the evidence from multiple correlated
SNPs, we show that the original finding from a GWAS
with a nominal P-value of 5.4 107 has been
significantly replicated in one cohort. Further studies
on PCLO/Piccolo in the etiology of mood disorders
and a joint analysis of correlated SNPs in finemap-
ping studies are both highly recommended.
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Absolute value of the Z-score vs. r relative to
rs2522833 for twenty-nine SNPs in Piccolo
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Figure 1 Linear fit between the observed genetic effects on
MDD at the markers and the absolute value of the
correlation between markers and the potentially causal
variant, rs2522833. Although not the Z-score but the
correlation coefficient between marker and phenotype is
expected to scale linearly with LD, for correlation coeffi-
cients up to rB0.7 (an unrealistically high genotype–
phenotype correlation for a complex trait), Z-scores are a
good proxy for r (a simulation in Visual Basic Macro in
Excel is available from the first author to show this). Note
that using absolute values implicitly assumes (in agreement
with the theory) that the direction of the association with
the phenotype aligns with the direction of LD between
single nucleotide polymorphism (SNPs). Assuming this
allows for the least manipulation of earlier published data,
and because the simulation study presented below incor-
porates this limitation, our conclusions will not be biased.
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Figure 2 Empirical probability to jointly observe a Z and a
C, which is equally or less likely than the observed values,
T1 and T2, in the Australian replication cohort. Simulations
were carried out using GWAsimulator conditioning on the
sample size of the replication cohort and the local LD
structure between the 29 single nucleotide polymorphism
(SNPs) in the study. Realistic genetic effect sizes were
modeled assuming multiplicative penetrance. The null
hypothesis of no replication is represented by relative risk
(RR) = 1. In all, 10 000 replicates were simulated, except for
RR = 1 in which 50 000 replicates were used to more
accurately estimate the low empirical probability under
the null hypothesis.
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